HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30.

Abstract
BMY-40481-30 is a new, water-soluble derivative and probable prodrug of etoposide characterized by the presence of a phosphate group in position 4' of the E ring of the etoposide molecule. The compound was only weakly cytotoxic in vitro and, consequently, an investigation of its antitumor activity was conducted in several murine and human tumor (xenograft) models. Etoposide was administered ip or po whereas BMY-40481-30 was given ip, po or iv. The potency of the derivative, when administered parenterally, as defined on the basis of maximum tolerated dose (MTD), was less than the parent compound on a weight (mg/kg) basis in some experiments but comparable to etoposide in other instances. Comparison at the MTD of the two compounds showed that BMY-40481-30 administered ip was as active as etoposide against ip P388 leukemia. BMY-40481-30 given iv was more active than etoposide given ip in two of five experiments versus iv P388 leukemia, but the two compounds were comparably active in the other three studies. Of particular interest was the finding that the derivative was more active than the parent compound at many of the comparable (on a mg/kg basis) dose levels of both evaluated po versus iv P388 leukemia; MTD levels were not achieved, and hence not compared, for either compound using the po route of administration. Both etoposide and BMY-40481-30 yielded comparable maximum effects against ic P388 leukemia, ic L1210 leukemia, and sc B16 melanoma, but etoposide was more efficacious versus sc M5076 sarcoma.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsW C Rose, G A Basler, P A Trail, M Saulnier, A R Crosswell, A M Casazza
JournalInvestigational new drugs (Invest New Drugs) Vol. 8 Suppl 1 Pg. S25-32 ( 1990) ISSN: 0167-6997 [Print] United States
PMID2380014 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Organophosphorus Compounds
  • etoposide phosphate
  • Etoposide
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Colonic Neoplasms (drug therapy, pathology)
  • Drug Screening Assays, Antitumor
  • Etoposide (analogs & derivatives, pharmacology)
  • Humans
  • Leukemia L1210 (drug therapy)
  • Leukemia P388 (drug therapy)
  • Lung Neoplasms (drug therapy, pathology)
  • Melanoma, Experimental (drug therapy, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred Strains
  • Neoplasm Transplantation
  • Organophosphorus Compounds (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: